Alignment Healthcare market cap ALHC
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Nov 2, 2026
- $1.5B
- Highest close in our data
- $5B
- Jun 2021
Alignment Healthcare is worth $1.5B at the close on Nov 2, 2026, at $7.00 a share.
That is down 55% over the last year and down 65% over five years.
Its highest close in our data was $5B in Jun 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.5B | $1.5B | $4.9B | −61% |
| 2025 | $3.8B | $2.2B | $4.1B | +81% |
| 2024 | $2.1B | $886.3M | $2.6B | +27% |
| 2023 | $1.6B | $975.9M | $2.4B | −26% |
| 2022 | $2.2B | $1.2B | $3.4B | −16% |
| 2021 | $2.6B | $2.4B | $5B | n/a |
Against its peers
Companies in Healthcare nearest Alignment Healthcare's size, closest first, today.
| Company | Market cap |
|---|---|
| ALHCAlignment Healthcare | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| PNTGPennant | $1.4B |
| ANABAnaptysbio | $1.4B |
| HLFHerbalife | $1.4B |
| CNMDCONMED | $1.4B |
| PAHCPhibro Animal Health | $1.6B |
| EYENational Vision | $1.4B |
| CDRECadre | $1.3B |
| TRUPTrupanion | $1.3B |
| ANIPANI Pharmaceuticals | $1.6B |
| Peer median | $1.4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Alignment Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.